TheJobsMapRedesign Science jobs and careers
New York, NY, United States
About Redesign Science
Redesign Science develops and applies a molecular dynamics-driven platform for in silico drug discovery against emerging drug target classes. We work in partnership with Biotech and Pharma to co-develop novel small molecule therapeutics.
Founded in 2017 by David Rooklin and Haotian Li.
- Founded
- 2017
- Employees
- 11 to 50
- Total funding
- $17M
- Headquarters
- New York
Leadership
The top of Redesign Science's org chart, with how many people report into each leader.
DR
David Rooklin
CEO
3 reports
BG
Brady Garabato
Senior Scientist
JZ
Janan Zhu
Head of Engineering
AA
Andrew Avorn
General Counsel
Jobs at Redesign Science
No open positions right now. Explore more companies on TheJobsMap.